The long-anticipated Cambridge Cancer Research Hospital will finally break ground this year after securing government approval. This state-of-the-art facility, designed to integrate research and clinical care, will be built on Cambridge’s biomedical campus. Completion is expected between 2025 and 2030.
The announcement has brought relief and optimism, particularly for South Cambridgeshire MP Pippa Heylings. She called the decision “hugely relieving” for both the region and the country. The seven-storey hospital, approved in April 2024, will feature 77 single-patient rooms and aims to revolutionise cancer treatment by bringing leading experts together under one roof.
Progress on the project stalled while the Labour government reviewed its funding and viability. Now that funding is confirmed, construction can move forward. Heylings, a Liberal Democrat, highlighted the hospital’s potential to transform cancer care. “This hospital could rewrite the story of cancer,” she said. “But missed opportunities in prevention, detection, and treatment have already cost lives. That’s why this decision is so crucial.”
In addition to the cancer hospital, Hinchingbrooke Hospital near Huntingdon will receive up to £1 billion in upgrades by 2028. The facility, which relies heavily on reinforced autoclaved aerated concrete (Raac), has been flagged as a safety risk. In response, hospital staff were trained in October on emergency evacuation procedures in case of a roof collapse.
The government’s investment marks a major step forward in healthcare infrastructure for the region. The Cambridge Cancer Research Hospital aligns with broader efforts to establish the city as a global leader in medical innovation. Meanwhile, the upgrades to Hinchingbrooke Hospital will improve patient safety and modernise its ageing facilities.
As construction begins, healthcare professionals and researchers remain hopeful that these developments will enhance patient care and drive groundbreaking cancer research. The Cambridge Cancer Research Hospital, in particular, is set to become a hub of innovation, potentially shaping the future of cancer treatment worldwide.
